z-logo
Premium
Colorectal adenocarcinoma with mucinous component: relation of MMP ‐13, EGFR , and E ‐cadherin expressions to clinicopathological features and prognosis
Author(s) -
Foda Abd AlRahman Mohammad,
ElHawary Amira Kamal,
Aziz Azza Abdel
Publication year - 2015
Publication title -
apmis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 88
eISSN - 1600-0463
pISSN - 0903-4641
DOI - 10.1111/apm.12379
Subject(s) - perineural invasion , medicine , adenocarcinoma , colorectal cancer , immunohistochemistry , colorectal adenocarcinoma , tissue microarray , cadherin , univariate analysis , mucinous carcinoma , oncology , pathology , gastroenterology , cancer , biology , multivariate analysis , genetics , cell
The aim of this study was to compare colorectal adenocarcinoma with mucinous component, ordinary adenocarcinoma ( OA ) and mucinous adenocarcinoma ( MA ) regarding clinicopathological parameters, survival, EGFR , MMP ‐13, and E ‐cadherin. We studied tumor tissue specimens from 28 patients with adenocarcinoma with mucinous component, 47 with OA , and 56 with MA , who underwent radical surgery from J anuary 2007 to J anuary 2012 at the G astroenterology C entre, M ansoura U niversity, E gypt. High density manual tissue microarrays were constructed and immunohistochemistry for EGFR , MMP ‐13, and E ‐cadherin was done. Colorectal adenocarcinoma with mucinous component ( AWMC ) was significantly associated with more perineural invasion, lower EGFR , and MMP ‐13 expressions than OA , with no difference in E ‐cadherin expression. Conversely, only microscopic abscess formation was significantly more with colorectal AWMC than MC with no difference in EGFR , MMP ‐13 and E ‐cadherin expression between both groups. Colorectal AWMC showed a better survival than MA with no difference with OA . In a univariate analysis, EGFR , MMP ‐13, and E ‐cadherin expressions did not show a significant impact on disease‐free or overall survival in patients with colorectal AWMC . Colorectal AWMC remains a vague entity that resembles OA in some clinicopathological and molecular respects as well as MA .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom